OX40 agonist (Apogenix)

N/A

Report date: 2025/03/19 11:44:17
NME

Base Information

Drug NameOX40 agonist (Apogenix)
Drug Alias NameOX40 costimulator (Apogenix)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTumor necrosis factor receptor superfamily member 4 agonists
TargetsTumor necrosis factor receptor superfamily member 4
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApogenix Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesApogenix Gmbh
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A